Letter to the Editor: mRNA Vaccines in Urological Malignancies.
Publication
, Journal Article
Yang, L; Gao, G; Huang, J
Published in: Hum Gene Ther
October 2022
Duke Scholars
Published In
Hum Gene Ther
DOI
EISSN
1557-7422
Publication Date
October 2022
Volume
33
Issue
19-20
Start / End Page
1101 / 1102
Location
United States
Related Subject Headings
- mRNA Vaccines
- Vaccines
- Urologic Neoplasms
- Immunotherapy
- Humans
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
Citation
APA
Chicago
ICMJE
MLA
NLM
Yang, L., Gao, G., & Huang, J. (2022). Letter to the Editor: mRNA Vaccines in Urological Malignancies. Hum Gene Ther, 33(19–20), 1101–1102. https://doi.org/10.1089/hum.2022.29218.lya
Yang, Lu, Guangping Gao, and Jiaoti Huang. “Letter to the Editor: mRNA Vaccines in Urological Malignancies.” Hum Gene Ther 33, no. 19–20 (October 2022): 1101–2. https://doi.org/10.1089/hum.2022.29218.lya.
Yang L, Gao G, Huang J. Letter to the Editor: mRNA Vaccines in Urological Malignancies. Hum Gene Ther. 2022 Oct;33(19–20):1101–2.
Yang, Lu, et al. “Letter to the Editor: mRNA Vaccines in Urological Malignancies.” Hum Gene Ther, vol. 33, no. 19–20, Oct. 2022, pp. 1101–02. Pubmed, doi:10.1089/hum.2022.29218.lya.
Yang L, Gao G, Huang J. Letter to the Editor: mRNA Vaccines in Urological Malignancies. Hum Gene Ther. 2022 Oct;33(19–20):1101–1102.
Published In
Hum Gene Ther
DOI
EISSN
1557-7422
Publication Date
October 2022
Volume
33
Issue
19-20
Start / End Page
1101 / 1102
Location
United States
Related Subject Headings
- mRNA Vaccines
- Vaccines
- Urologic Neoplasms
- Immunotherapy
- Humans
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology